Alpha 2.0
Login Register
» Articles » PMID: 12021957

Proximal Myopathy and Diffuse White Matter Involvement in Myotonic Dystrophy Type I

Overview
Journal J Neurol
Specialty Neurology
Date 2002 May 22
PMID 12021957
Citations 1
Authors
Kayihan Uluc
E Murat Arsava
Sevim Erdem
Ersin Tan
Affiliations
Soon will be listed here.
Citing Articles

Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.

Voermans N, van der Bilt R, IJspeert J, Hogrel J, Jeanpierre M, Behin A J Neurol. 2019; 266(12):2987-2996.

PMID: 31471688 PMC: 6851043. DOI: 10.1007/s00415-019-09494-8.

References
1.
Chang L, Ernst T, Osborn D, Seltzer W, Poland R . Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. Arch Neurol. 1998; 55(3):305-11. DOI: 10.1001/archneur.55.3.305. View
2.
Ogata A, Terae S, Fujita M, Tashiro K . Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: an MRI and neuropathological study. Neuroradiology. 1998; 40(7):411-5. DOI: 10.1007/s002340050613. View
3.
Meola G . Clinical and genetic heterogeneity in myotonic dystrophies. Muscle Nerve. 2000; 23(12):1789-99. DOI: 10.1002/1097-4598(200012)23:12<1789::aid-mus2>3.0.co;2-4. View
4.
Glantz R, Wright R, Huckman M, Garron D, Siegel I . Central nervous system magnetic resonance imaging findings in myotonic dystrophy. Arch Neurol. 1988; 45(1):36-7. DOI: 10.1001/archneur.1988.00520250042017. View
5.
Fiorelli M, Duboc D, Mazoyer B, Blin J, Eymard B, Fardeau M . Decreased cerebral glucose utilization in myotonic dystrophy. Neurology. 1992; 42(1):91-4. DOI: 10.1212/wnl.42.1.91. View